Search

everythinglearnresearchcommunity

for

Search:↓

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Fenugreek leaf extracts significantly promoted hair growth in mice with alopecia.

Lasers in hair transplantation show promise but are not yet standard, with current methods causing some side effects and needles still being preferred for creating recipient sites.

A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

Proper hair care and suitable products are essential for men's scalp health and well-being.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

CRISPR/Cas9 gene-editing may effectively treat hair loss but requires more research for safe use.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Injecting a person's own fat into their scalp may help regrow hair and improve hair thickness in different types of hair loss.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Isotretinoin effectively reduces acne but causes dry skin, higher skin pH, more redness, and hair loss.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Grateloupia elliptica extract may help prevent hair loss and promote hair growth.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Treating hair loss in both men and women is effective and improves quality of life.